From Nasdaq: 2025-05-15 19:59:00

Aura Biosciences, Inc. (AURA) has announced a public offering of its common stock and related warrants, including pre-funded warrants for certain investors. The offering is subject to market conditions and being conducted under a shelf registration statement that became effective on April 5, 2024. Aura emphasized that the announcement does not constitute an offer to sell securities where unlawful. The final terms will be disclosed in a subsequent prospectus supplement. AURA closed at $5.18 on Thursday, up 5.71%, and is currently trading at $5.43 on the Nasdaq Global Market, up an additional 4.83%.



Read more at Nasdaq: Aura Biosciences Launches Public Offering Of Common Stock And Warrants